ANN ARBOR, Mich., Jan. 11, 2016 /PRNewswire/ -- Rubicon Genomics, Inc. today reported a 40% increase in year-over-year sales in 2015. Rubicon also announced the addition of new distributors in India and Poland. Rubicon is a leading provider of pre-analytical library preparation kits for the research market that increase the accuracy, efficiency and speed of routine genomic analysis. Rubicon's kits also enable analysis of challenging samples, such as cell-free DNA from plasma, also known as liquid biopsies, for cancer research.
"In 2015, Rubicon achieved a 40% rise in revenue, our fifth consecutive year of robust revenue growth, fueled by expansion of our distributor base, new product introductions, enhanced marketing activities and collaborations with key industry partners," commented Rubicon CEO James Koziarz, PhD. "Our success reflected gains across all our products. These included the launch of our new ThruPLEX® Plasma-seq kit that enables the use of circulating DNA for liquid biopsies in cancer research, our collaboration with Beckman Coulter to provide an automated ThruPLEX solution on its Biomek FXP Workstation, and the increasing use of our PicoPLEX™ technology in fertility-related research applications."
Dr. Koziarz continued, "Our progress is being noticed--in 2015 we were named one of Michigan's 50 Companies to Watch and Crain's Detroit Business ranked Rubicon among the state's top 25 companies in innovative intellectual property. We look forward to another record-setting year as adoption of our unique proprietary technologies for library preparation for genomic analysis continues to accelerate."
New distributor Delonix Healthcare Pvt. Ltd. provides advanced scientific tools, products and technologies to the research, industrial biotech, pharmaceutical and research hospital sectors in India. Biocena Ltd. is a life science distributor in Poland with an innovative online platform allowing scientists to access advanced research products and technologies.
Rubicon's DNA library preparation products for arrays and Illumina® next-generation sequencing (NGS) platforms include ThruPLEX® DNA-seq, ThruPLEX Plasma-seq, PicoPLEX DNA-seq, PicoPLEX WGA kits and TransPLEX® C-WTA kits.
For more information on Rubicon products, visit http://rubicongenomics.com/products/kit-selection-guide-2/
About Rubicon Genomics
Rubicon Genomics develops innovative, high quality, nucleic acid library preparation and companion products for research applications that enable easy, reliable, and highly sensitive analysis of samples. Rubicon is committed to teamwork and continuous improvement to provide excellence to our customers, shareholders, and employees. Privately-held Rubicon is located in Ann Arbor, Michigan. For more information, visit rubicongenomics.com.
SOURCE Rubicon Genomics, Inc.